In the field of medical injection molding, product surface cleanliness is paramount to ensuring the safety, functionality, and durability of medical devices. However, surface contamination issues—such as residual stains, oil spots, dust, or color defects—remain prevalent in actual production. These problems not only reduce product qualification rates but also pose risks of medical malpractice. This article delves into the root causes of surface contamination from four key perspectives: materials, processes, molds, and environmental control, while offering systematic solutions to address these challenges.
Medical-grade plastics (e.g., PC, PP, PPSU) containing impurities or low-molecular-weight volatiles can decompose under high temperatures, leaving residues on mold surfaces. For instance, inadequately dried materials may cause surface water streaking due to moisture vaporization.
Lubricants or antistatic agents added to enhance performance may exude onto surfaces if incompatible with the base material. A recall incident involved an infusion set with excessive lubricant, leading to bacterial adhesion.
Insufficient mixing of color masterbatch and base resin results in localized color defects. Medical products demand strict color consistency, as deviations affect device identification.
Solutions:
Excessive heat degrades materials (e.g., PVC decomposes above 180°C), producing carbonized particles. Insufficient heat causes filling defects, leaving flow marks. A catheter connector manufacturer faced periodic surface stains due to ±5°C barrel temperature fluctuations.
Low pressure prevents complete mold filling, creating burrs or sink marks that trap contaminants. Medical microfluidic chips require flow channel precision of ±0.001mm, demanding pressure control at 0.1 MPa increments.
Inadequate holding pressure leads to internal stress, causing surface cracks that harbor microorganisms.
Solutions:
Molds lacking exhaust slots trap gases, creating burn marks. Medical-grade LCP requires exhaust slots depth of 0.01–0.03mm due to its low viscosity.
A roughness (Ra) >0.8μm increases mold release agent adhesion, leaving mirror-like stains. An artificial joint component with Ra1.6μm caused postoperative infections.
Scale buildup in cooling channels distorts products via localized overheating. Medical molds demand deionized water cooling with regular EDI treatment.
Solutions:
Medical injection molding requires ISO Class 7 (10,000-grade) cleanrooms, but some facilities use ordinary rooms, resulting in 300x higher airborne particles (≥0.5μm), directly contaminating products.
Operators without cleanroom garments shed ~100,000 skin flakes per minute. Gloves replaced less frequently than every 2 hours significantly increase contamination risks.
Low-quality PE bags release plasticizers, as seen in a blood glucose meter case where packaging caused oily residue on detection windows.
Solutions:
Identify critical-to-cleanliness (CTC) characteristics during product development. One firm reduced 12 contamination risks via DFMEA analysis.
Monitor key parameters (e.g., melt temperature, pressure) using X-bar charts to achieve Cpk ≥1.67.
Organized workspaces reduced equipment dust accumulation by 82% in one case.
Achieving surface cleanliness in medical injection molding requires a multidisciplinary approach integrating material science, fluid mechanics, and microbiology. Enterprises must establish end-to-end traceability systems and leverage IoT for real-time data analytics. Only by embedding quality awareness into every process detail can they thrive under stringent medical regulations.